Cipla rises 3% as USFDA clears InvaGen plant
CIPLA Limited (CIPLA) rose as much as 3% to a day high of ₹1,435 on November 18, after the US Food and Drug Administration (USFDA) gave a clean chit to its InvaGen plant in New York. The stock traded at ₹1,432.80 at 11:37 AM, up 3.23% fro…



















